TissueGene-C is an injectable solution of normal and genetically modified allogeneic human chondrocytes in development for the treatment of knee osteoarthritis.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Feb 18, 2021 | Emerging Technology Report
TissueGene-C is an injectable solution of normal and genetically modified allogeneic human chondrocytes in development for the treatment of knee osteoarthritis.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Learn more about our Privacy Policy
This site uses cookies. By continuing to use this website, you agree to their use. For details, please review our Privacy Policy